Physician profile
George Law
NPI 1679533939
$544.74
in general payments reported to CMS, 2019-2025
11 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.01 · 2020: $20.75 · 2021: $69.69 · 2022: $46.82 · 2023: $23.93 · 2024: $113 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359 · Education: $23.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.54 |
| Education | $23.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $135.02 | 2025 | |
| Teleflex LLC | $133.21 | 2022-2025 | Deknatel |
| Boston Scientific Corporation | $132.85 | 2021-2024 | Moses 550 Dfl, Ams 700 |
| Travere Therapeutics, INC. | $24.44 | 2022 | |
| Sumitomo Pharma America, INC. | $23.93 | 2023 | Orgovyx |
| Integra Lifesciences Corporation | $20.95 | 2021 | |
| Blue Earth Diagnostics | $20.75 | 2020 | |
| Progenics Pharmaceuticals, INC. | $16.57 | 2024 | |
| Endo Pharmaceuticals INC. | $13.12 | 2019 | |
| Allergan, INC. | $12.01 | 2021 | |
| Antares Pharma, INC. | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.